Skip to main content
. 2020 Aug 19;9(9):515–522. doi: 10.1002/psp4.12538

Figure 2.

Figure 2

Simulated steady‐state pharmacokinetics for assessing weight‐based vs. fixed‐dose approach. Area under the concentration‐time curve at steady‐state (AUCss) using a weight‐based 45 mg/kg (a) vs. a fixed‐dose 3,375 mg approach (b). Maximum concentration at steady‐state (Cmaxss, µg/mL) using a weight‐based 45 mg/kg (c) vs. fixed‐dose 3,375 mg approach (d).